A chronic condition affecting about a million Americans, Crohn’s disease causes inflammation in the digestive tract, leading to symptoms of diarrhea, cramping, abdominal pain and weight loss. Steroids ...

A chronic condition affecting about a million Americans, Crohn's disease causes inflammation in the digestive tract, leading ...

Lavanya Reddivari, associate professor of food science, finds that blueberries may be the key to fighting gut disease.

Ease the symptoms of a UC flare, such as diarrhea, abdominal pain, and fever using expert-backed tips, and learn when to seek ...

Discover the latest press releases from Crohn's & Colitis Foundation with the Atlanta Business Chronicle's BizSpotlight ...

Eli Lilly has the results it was looking for in a second, confirmatory trial of its anti-IL-23p19 antibody mirikizumab in ulcerative colitis as it waits for the outcome of regulatory reviews in the US ...

In the third quarter of 2025, Mirador closed a $250 million Series B financing, bringing total capital raised to more than $650 million since the company launched in March 2024. The proceeds enable ...

France's Finance ​Ministry said on Monday it had received no formal request for investment approval ‌regarding French biotech ...

Abivax (ABVX) stays a Buy as obefazimod UC data fuels multi‑billion potential; 2026 Phase 3/NDA catalysts loom and M&A ...

France's Finance Ministry refutes reports of Eli Lilly's intent to acquire French biotech Abivax for €15 billion. Abivax shares spiked following the rumors but receded after the Ministry's denial.

In January 2022, Garutadustat, the innovative, potentially best-in-class, oral PHD inhibitor was nominated as a preclinical ...

SKYWAY (NCT07148414) is a Phase 2 basket trial of SPY072 (anti-TL1A) in patients with moderate to severely active RA, PsA, or axSpA. Enrollment is on track, and all indications are expected to readout ...